Atria Wealth Solutions’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-2,823
Closed -$556K 1990
2024
Q3
$556K Buy
2,823
+1,115
+65% +$232K 0.01% 1194
2024
Q2
$353K Sell
1,708
-1,150
-40% -$261K ﹤0.01% 1412
2024
Q1
$774K Buy
2,858
+696
+32% +$166K 0.01% 1033
2023
Q4
$511K Sell
2,162
-105
-5% -$20.6K 0.01% 1196
2023
Q3
$444K Sell
2,267
-62
-3% -$12.7K 0.01% 1186
2023
Q2
$490K Sell
2,329
-44
-2% -$8.75K 0.01% 1170
2023
Q1
$479K Sell
2,373
-37
-2% -$8.38K 0.01% 1165
2022
Q4
$525K Sell
2,410
-289
-11% -$63.1K 0.01% 1057
2022
Q3
$531K Buy
2,699
+95
+4% +$20.5K 0.01% 986
2022
Q2
$557K Sell
2,604
-13
-0.5% -$3.18K 0.01% 917
2022
Q1
$743K Buy
+2,617
New +$807K 0.01% 857

Other funds holding CRL